Eton Pharmaceuticals Inc (ETON) — Capital Reinvestment Ratio
Eton Pharmaceuticals Inc (ETON) has a Capital Reinvestment Ratio of 0.02x as of September 2025, meaning it reinvests 0% of its operating cash flow ($12.03 Million) in capital expenditures ($284.00K). See Eton Pharmaceuticals Inc net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Eton Pharmaceuticals Inc Capital Reinvestment Ratio (2022–2025)
This chart tracks Eton Pharmaceuticals Inc's Capital Reinvestment Ratio across 4 annual periods. Check ETON cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Eton Pharmaceuticals Inc (2022–2025)
Year-by-year Capital Reinvestment Ratio for Eton Pharmaceuticals Inc from 2022 to 2025. For live market cap and broader valuation context, see Eton Pharmaceuticals Inc stock valuation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.03x | $10.52 Million | $333.00K | ▲ +17.9% |
| 2024 | 0.03x | $969.00K | $26.00K | ▼ -76.4% |
| 2023 | 0.11x | $6.82 Million | $775.00K | ▼ -80.3% |
| 2022 | 0.58x | $4.82 Million | $2.79 Million | — |